Use of PRO In Cell and Gene Therapy Studies
Patient reported outcomes provide an important dimension to assessing the overall patient impact from a novel treatment. Listen as Robin Bliss describes the appropriate execution of PROs using clearly defined endpoints, measurable changes within context to the indication and disease progression, and several other key considerations for deployment in cell and gene therapy studies.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.